Cellanyx

The absence of reliable predictive diagnostic tests has emerged as a major barrier to personalized medicine in cancer. Cellanyx’s phenotypic platform directly assesses the dynamic behavior of live biopsy cells, uniquely quantifying the hallmarks of cancer and cancer aggressiveness such as cell movement and protein dynamics.